A preliminary assessment of titles and abstracts was conducted
Metabolic indicators that may correlate with reduced GLP-1 activity include: Persistent hyperglycemia despite dietary modifications, particularly elevated postprandial (after-meal) blood glucose levels Difficulty achieving satiety after meals, leading to continued hunger and frequent snacking Progressive weight gain that is resistant to conventional dietary interventions Diagnosis of prediabetes or type 2 diabetes , conditions associated with impaired incretin response Metabolic syndrome features , including central obesity, hypertension, and dyslipidemia It is important to emphasize that these signs are not diagnostic of GLP-1 imbalance specifically, as they can result from numerous metabolic, endocrine, or lifestyle factors
Similarly, each cell is also exposed to oxidative damage caused by outside chemicals and toxins
With 1 in 5 patients developing deficiencies within a year, the current "wait and see" approach isn't serving our patients
They did all send instructions for how to inject the medications safely, and the Henry practitioner who conferenced with me gave a very clear visual tutorial
If your insurance covers GLP-1 medications with reasonable copays, that may be more cost-effective